PharmaResearch announced on the 11th that it has signed an exclusive supply agreement for “Rejuran” with Brazilian aesthetic company Dermadream.

The agreement was concluded last month at the “IMCAS World 2026” global aesthetics congress held in Paris, France. In accordance with mutual agreement, the specific scale of the contract was not disclosed.

PharmaResearch plans to push ahead with local distribution and business development in Brazil as soon as medical device approval from ANVISA, the Brazilian Health Regulatory Agency, is completed.

Brazil is the largest aesthetic market in Latin America, with steadily increasing demand for cosmetic procedures and skin regeneration solutions. Taking this into account, PharmaResearch explained that it has designated Brazil as a key country in the Latin American region and is pursuing a long-term market entry strategy there.

Partner company Dermadream is an aesthetics specialist with a solid sales and marketing network in the Brazilian market. A PharmaResearch representative said, “This agreement is an important foundation for expanding into the Latin American market as part of the company’s global expansion strategy,” adding, “The company will develop its business in a phased and stable manner, taking into consideration local regulations and market characteristics.”

Meanwhile, PharmaResearch is continuously expanding collaboration with overseas partners for global market entry. Last year, it signed a partnership agreement with French aesthetic company Vivacy to enter 22 European countries, including the United Kingdom, Germany, France, Italy, and Spain.

Popular News